rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

500359 RANBAXY Group (A)

Ranbaxy Laboratories Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
562.80   9.70   1.75%
Volume 116,641
Prev close 553.10
Day's H/L (Rs.) 564.00 - 555.45
52wk H/L (Rs.) 564.00 - 253.95
Mkt Cap (Rs. Cr) 23,862.72
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

RANBAXY

Ranbaxy Laboratories Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
562.50   9.65   1.75%
Volume 974,818
Prev close 552.85
Day's H/L (Rs.) 564.30 - 555.30
52wk H/L (Rs.) 564.75 - 253.65
Turnover (Rs. Lacs) 5,465.41
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Ranbaxy Laboratories Ltd.  (See all 1,584 market voices)   

140 Characters
  Cancel
Share Bazari - 18 hour(s) ago Rocking performance continues at our Community on Facebook, 2 calls both hit the target. From last two months we are providing the best results and Its Free. Just LIKE us on facebook. visit our community & see our result and view of our followers. We have more than 900 followers now . Follow us as www dot facebook dot com/sharebazari.
#Ranbaxy-Laboratories-Ltd
Reply   |   Share
Preeti Nigam - 1 day(s) ago Dear Trader, do not go with rumours take advise/tips from SEBI Registered investment adviser only for more information visit http://rediff.ly/2v5ks and register
#Ranbaxy-Laboratories-Ltd
Reply   |   Share

Realtime news for Ranbaxy Laboratories Ltd. (See all 890 news)

22 July 2014, 14:42
Ranbaxy-Sun Pharma deal gets nod from BSE, NSE - 2 hour(s) ago
Sun Pharma surges on getting nod from BSE, NSE for Ranbaxy deal - 2 hour(s) ago
Sun Pharma pops buyout pill again - 5 day(s) ago
Pharmaceutical companies like Ranbaxy Laboratories, Sanofi India and others fume at price control order - 15 Jul 2014
RANBAXY LABORATORIES : Patent Application Titled "Multiparticulate Extended-Release Composition of Mesalamine" Published Online - 10 Jul 2014

BSE Announcements from Ranbaxy Laboratories Ltd. (See all)

Allotment of Equity Shares - 14 Jul 2014
AGM on July 28, 2014 - 10 Jul 2014

Company details for Ranbaxy Laboratories Ltd.

Report Card

PE Ratios
-26.64
EPS (Rs.)
-20.76
Sales (Rs. Cr)
1,252.02
Face Value (Rs.)
5
Net Profit
Margin (%)
 
-11.49
Last Bonus
3:5
Last Dividend(%)
40
Return on
Average Equity
 
-80.16

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Ranbaxy Laboratories Ltd. performance snapshot

If you had invested Rs.  in Ranbaxy Laboratories Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Ranbaxy Laboratories Ltd. with other stocks

Lupin Ltd.
1,091.80
GlaxoSmithKline Pharmaceuticals Ltd.
2,498.60
Show more companies
Lupin Ltd.
1,091.80
GlaxoSmithKline Pharmaceuticals Ltd.
2,498.60
Divi's Laboratories Ltd.
1,487.15
Piramal Enterprises Ltd.
642.30
Apollo Hospitals Enterprise Ltd.
1,100.40
Strides Arcolab Ltd.
665.00
Ipca Laboratories Ltd.
860.60
Sun Pharmaceutical Industries Ltd.
741.30
Cipla Ltd.
437.15
Aurobindo Pharma Ltd.
743.40
Show less companies
Close
Add Ranbaxy Laboratories Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ranbaxy Laboratories Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close